Key facts
- This page summarizes Bo Ethan Wang's Form 3 filing for Yuanbao Inc. (YB).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 13:00.
Bo Ethan Wang - 18 Mar 2026 Form 3 Insider Report for Yuanbao Inc. (YB)
- Reporting relationship
- Chief Technology Officer
- Issuer ticker
- YB
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Wang Bo
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Bo Ethan Wang filed Form 3 for Yuanbao Inc. (YB) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002116706
Primary reporting owner
Wang Bo Ethan
- Relationship
- Chief Technology Officer
- Address
- BUILDING 2, NO.8 BEICHEN WEST ROAD, CHAOYANG DISTRICT, BEIJING, CHINA
- Signature
- /s/ Wang Bo
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
YB
holding
Class A ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,299,986
- Date
- 18 Mar 2026
- Ownership
- By Global Running Lion Limited
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
YB
holding
Derivative
Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A ordinary share
- Underlying amount
- 300,000
- Exercise price
- $0.0600
- Footnotes
- F2
YB
holding
Derivative
Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A ordinary share
- Underlying amount
- 100,000
- Exercise price
- $0.1500
- Footnotes
- F3
YB
holding
Derivative
Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A ordinary share
- Underlying amount
- 100,000
- Exercise price
- $0.2500
- Footnotes
- F4
YB
holding
Derivative
Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A ordinary share
- Underlying amount
- 100,000
- Exercise price
- $0.3500
- Footnotes
- F5
YB
holding
Derivative
Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A ordinary share
- Underlying amount
- 60,000
- Exercise price
- $0.4000
- Footnotes
- F6
YB
holding
Derivative
Restricted Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A ordinary share
- Underlying amount
- 90,000
- Exercise price
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents 6,299,986 Class A ordinary shares held by Global Running Lion Limited and beneficially owned by the Reporting Person.
Footnote F2
The options have become fully vested and exercisable on August 1, 2024. Each Option entitles the holder to purchase one share of the Issuer's Class A ordinary share upon exercising.
Footnote F3
The options have become fully vested and exercisable on August 1, 2025. Each Option entitles the holder to purchase one share of the Issuer's Class A ordinary share upon exercising.
Footnote F4
The options vest in four installments of 15%, 25%, 30% and 30% of the total grant on each of September 1, 2023, September 1, 2024, September 1, 2025 and September 1, 2026, respectively. Each Option entitles the holder to purchase one share of the Issuer's Class A ordinary share upon exercising.
Footnote F5
The options vest in four installments of 15%, 25%, 30% and 30% of the total grant on each of October 1, 2025, October 1, 2026, October 1, 2027 and October 1, 2028, respectively. Each Option entitles the holder to purchase one share of the Issuer's Class A ordinary share upon exercising.
Footnote F6
The options vest in four installments of 15%, 25%, 30% and 30% of the total grant on each of April 1, 2026, April 1, 2027, April 1, 2028 and April 1, 2029, respectively. Each Option entitles the holder to purchase one share of the Issuer's Class A ordinary share upon exercising.
Footnote F7
The RSUs vest in four installments of 15%, 25%, 30% and 30% of the total grant on each of November 20, 2026, November 20, 2027, November 20, 2028 and November 20, 2029, respectively. Each RSU represents a contingent right to receive one share of the Issuer's Class A ordinary share upon vesting.